GUIDE — SUPPLEMENT

Berberine: LDL, Blood Sugar, and the Cardiometabolic Evidence

Dr. Regina Druz, MD, MBA, FACC, FMCP-M·Reviewed May 2026·5 min read
Quick summary

Berberine is a natural compound from barberry, goldenseal, and Oregon grape that activates AMPK and inhibits PCSK9 — reducing LDL by ~18 mg/dL, triglycerides by ~13 mg/dL, and significantly improving blood sugar. It is the ideal supplement for patients with elevated cholesterol and metabolic syndrome or elevated blood sugar. Not a statin replacement for high-risk patients. Take with meals to reduce GI side effects.

Key clinical numbers

−18 mg/dL
LDL reduction
−13 mg/dL
Triglyceride reduction
+2.3 mg/dL
HDL increase

Averages from a 2015 meta-analysis of randomised trials. Individual results vary with baseline lipids and metabolic profile.

The evidence

Berberine is a natural alkaloid found in several plants including goldenseal, barberry, and Oregon grape. It has been used in traditional Chinese and Ayurvedic medicine for centuries and is now recognized by modern science for its powerful cardiometabolic benefits.

Mechanism — two pathways working together: Berberine inhibits PCSK9, a protein that normally degrades LDL receptors on liver cells. By blocking PCSK9, berberine allows the liver to maintain more LDL receptors on its surface, enabling it to clear more LDL from the bloodstream. This is the same principle behind injectable PCSK9-inhibitor medications, achieved here through a natural compound. Berberine also activates AMPK — the same cellular energy sensor activated by metformin — which reduces hepatic cholesterol production and improves insulin sensitivity simultaneously.

Key clinical trial: A landmark 2026 trial published in JAMA Network Open confirmed that 1 g/day of berberine significantly reduced both ApoB (a key cardiovascular risk marker) and hs-CRP (an inflammation marker) in patients with obesity and metabolic liver disease. A 2012 meta-analysis of 27 RCTs found berberine reduced LDL by an average of 18 mg/dL, total cholesterol by 18 mg/dL, and triglycerides by 13 mg/dL compared to placebo — clinically meaningful effects for a non-prescription supplement.

The metabolic crossover advantage: Berberine’s true differentiation is its dual action on both lipids and blood glucose. It significantly improves how the body handles blood sugar — making it particularly valuable for patients with metabolic syndrome, who typically have both elevated cholesterol and impaired glucose metabolism. It also reduces inflammation markers (hs-CRP), offering a comprehensive approach to metabolic cardiovascular risk.

Dose, form & what to look for

Standard dose

1,000 mg per day, taken as 500 mg twice daily with meals. This divided dosing with food is important — it significantly reduces the GI side effects some people experience. Full lipid-lowering effects typically emerge over 8–12 weeks of consistent use; blood sugar improvements may be seen sooner.

What to look for on the label: Berberine HCl (hydrochloride salt form — the most studied and bioavailable). Dose clearly stated per capsule, not hidden in a blend. Third-party tested (NSF, USP, or Informed Sport). Avoid products combining berberine with multiple other active ingredients at unknown doses.

Bioavailability note: Berberine has relatively poor oral bioavailability on its own. Some newer formulations use dihydroberberine or berberine phytosome to improve absorption. These may be effective at lower doses — follow label dosing for the specific form.

Side effects & drug interactions

GI tolerance

The most common issue with berberine is mild gastrointestinal upset — nausea, loose stools, or stomach cramps. This is significantly reduced by taking berberine with meals rather than on an empty stomach. Starting with a lower dose (250 mg twice daily) and gradually increasing over 2–4 weeks also helps.

Critical drug interactions
  • Metformin: shares berberine’s AMPK mechanism — combining can have additive blood-sugar-lowering effects. Inform your physician and monitor glucose closely.
  • Cyclosporine (critical): do not combine without specialist supervision. Berberine inhibits CYP3A4 and P-glycoprotein, which can raise cyclosporine to potentially toxic levels.
  • Other CYP3A4 substrates: can affect certain statins (simvastatin, lovastatin) and some anticoagulants — review your medication list with your physician.
  • Liver monitoring: with long-term use (>6 months), periodic AST/ALT monitoring is reasonable, particularly if combining with a statin.
  • Pregnancy & breastfeeding: avoid — insufficient safety data, with some animal data suggesting harm.

Frequently asked questions

Who is berberine best suited for?+

Berberine is the ideal supplement for patients who have elevated cholesterol and elevated blood sugar or metabolic syndrome. Its dual action on lipids (lowering LDL ~18 mg/dL and triglycerides ~13 mg/dL) and on glucose metabolism makes it more comprehensive than a lipid-only supplement. It is not a statin replacement for high-risk patients.

How long does berberine take to work?+

Full lipid-lowering effects typically emerge over 8–12 weeks of consistent use, while blood sugar improvements may be seen sooner. Take 500 mg twice daily with meals throughout, and reassess with repeat bloodwork — Dr. Druz typically checks a lipid panel and metabolic markers at around 3 months.

How do I reduce berberine’s GI side effects?+

The most common issue is mild GI upset — nausea, loose stools, or cramps. Taking berberine with meals rather than on an empty stomach significantly reduces this. Starting at a lower dose (250 mg twice daily) and gradually increasing over 2–4 weeks also helps your gut adjust.

Can I take berberine with metformin?+

Berberine and metformin share the same AMPK mechanism, so combining them can have additive blood-sugar-lowering effects. This isn’t automatically unsafe, but you should inform your physician before starting berberine and monitor your glucose levels closely to avoid hypoglycaemia.

What form of berberine should I look for?+

Choose berberine HCl (hydrochloride) — the most studied and bioavailable form — with the dose clearly stated per capsule (not hidden in a proprietary blend) and third-party testing. Newer dihydroberberine or berberine phytosome formulations improve absorption and may work at lower doses; follow the label dosing for the specific form.

References

  1. Kong WJ, et al. Berberine reduces insulin resistance through protein kinase Cθ. Metabolism. 2009;58(1):109–119.
  2. Lan J, et al. Meta-analysis of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia, and hypertension. J Ethnopharmacol. 2015;161:69–81.
Medical disclaimer

This guide is for educational purposes only and does not constitute medical advice. Always consult a qualified physician before starting any supplement, particularly if you are taking anticoagulants, statins, or other cardiovascular medications.

Medically reviewed by Dr. Regina Druz, MD, MBA, FACC, FMCP-M — Board-Certified Integrative Cardiologist at Holistic Heart Centers, Roslyn, NY. Last reviewed: May 2026.

From the Shop